JamesAndrewde LemosMD

PubMed

• Small Peptide, Large Implications: Endotrophin in Heart Failure with Preserved Ejection Fraction.
  Lisandro Maya-Ramos, Philipp E Scherer, James A de Lemos
  Clinical Chemistry. 2023-08-02
• 6 citations
  Use of optimal medical therapy in patients with diabetes and atherosclerotic cardiovascular disease: Insights from a prospective longitudinal cohort study.
  Suzanne V Arnold, James A de Lemos, Luke Zheng, Robert S Rosenson, Christie M Ballantyne
  Diabetes, Obesity & Metabolism. 2023-06-01
• 2 citations
  Multi-marker risk assessment in patients hospitalized with COVID-19: Results from the American Heart Association COVID-19 Cardiovascular Disease Registry.
  Ankeet S Bhatt, Lori B Daniels, James de Lemos, Erica Goodrich, Erin A Bohula
  American Heart Journal. 2023-04-01

Journal Articles

• Ezetimibe Added to Statin Therapy after Acute Coronary Syndromes  
  Cannon CP, Blazing MA, Giugliano RP, McCagg A, White JA, Theroux P, Darius H, Lewis BS, Ophuis TO, Jukema JW, De Ferrari GM, Ruzyllo W, De Lucca P, Im K, Bohula EA, Re..., N Engl J Med, 1/1/2015
• Reply—safety of same-day discharge after percutaneous coronary intervention: what is the level of evidence?  
  Brayton KM, Patel VG, Stave C, Kumbhani DJ, J Am Coll Cardiol, 1/1/2014
• Application of the new cholesterol guidelines  
  Paixao AR, Khera A, N Engl J Med, 1/1/2014
• Early clopidogrel versus prasugrel use among contemporary STEMI and NSTEMI patients in the US: Insights from the National Cardiovascular Data Registry  
  Sherwood MW, Wiviott SD, Peng SA, Roe MT, Peterson ED, Wang TY, J Am Heart Assoc, 1/1/2014
• Measures of adiposity and fat distribution and risk of diabetes—reply [response]  
  Neeland IJ, Turer AT, JAMA, 1/1/2013
• Assays for cardiac troponins—reply[response]  
  de Lemos JA, JAMA, 1/1/2013
• 2013 ACCF/AHA Guideline for the Management of ST-Elevation Myocardial Infarction: A Report of the American College of Cardiology Foundation/American Heart Association ...  
  O'Gara PT, Kushner FG, Ascheim DD, Casey DE Jr, Chung MK, Ettinger SM, Fang JC, Fesmire FM, Franklin BA, Granger CB, Krumholz HM, Linderbaum JA, Morrow DA, Newby LK, O..., Circulation, 1/17/2012
• 2013 ACCF/AHA Guideline for the Management of ST-Elevation Myocardial Infarction: Executive Summary: A Report of the American College of Cardiology Foundation/American...  
  O'Gara PT, Kushner FG, Ascheim DD, Casey DE Jr, Chung MK, Ettinger SM, Fang JC, Fesmire FM, Franklin BA, Granger CB, Krumholz HM, Linderbaum JA, Morrow DA, Newby LK, O..., J Am Coll Cardiol, 1/13/2012
• 2013 ACCF/AHA Guideline for the Management of ST-Elevation Myocardial Infarction: A Report of the American College of Cardiology Foundation/American Heart Association ...  
  O'Gara PT, Kushner FG, Ascheim DD, Casey DE Jr, Chung MK, Ettinger SM, Fang JC, Fesmire FM, Franklin BA, Granger CB, Krumholz HM, Linderbaum JA, Morrow DA, Newby LK, O..., J Am Coll Cardiol, 1/12/2012
• Lack of effect of lowering LDL cholesterol on cancer: meta-analysis of individual data from 175,000 people in 27 randomised trials of statin therapy  
  Cholesterol Treatment Trialists' (CTT) Collaboration, PLoS One, 1/1/2012
• Comparison of the Prognostic Value of Peak Creatine Kinase-MB and Troponin Levels Among Patients With Acute Myocardial Infarction: A Report from the Acute Coronary Tre...  
  Chin CT, Wang TY, Li S, Wiviott SD, Kontos MC, Peterson ED, Roe MT, Clin Cardiol, 1/1/2012
• Severe obesity and ST elevation myocardial infarction: the evolving challenge [response]  
  Das Sr, de Lemos JA, J Am Coll Cardiol, 1/1/2012
• Rates of cardiac catheterization cancellation for ST elevation myocardial infarction after activation by emergency medical services or emergency physicians; results fr...  
  Neeland IJ, de Lemos JA, Circulation, 1/1/2012
• Third universal definition of myocardial infarction  
  Thygesen K, Alpert JS, Jaffe AS, Simoons ML, Chaitman BR, White HD; the Writing Group on behalf of the Joint ESC/ACCF/AHA/WHF Task Force for the Universal Definition o..., JACC, 1/1/2012
• Third universal definition of myocardial infarction  
  Thygesen K, Alpert JS, Jaffe AS, Simoons ML, Chaitman BR, White HD; the Writing Group on behalf of the Joint ESC/ACCF/AHA/WHF Task Force for the Universal Definition o..., Eur Heart J, 1/1/2012
• The GoodNEWS (Genes, Nutrition, Exercise, Wellness, and Spiritual Growth) Trial: a community-based participatory research (CBPR) trial with African-American church con...  
  DeHaven MJ, Ramos-Roman MA, Gimpel N, Carson J, Pickens S, Simmons C, Powell-Wiley T, Banks-Richard K, Shuval K, Duval J, Tong L, Hsieh N, Lee JJ, Contemp Clin Trials, 1/1/2011
• Highly sensitive cardiac troponin T assay, cardiac disease, and mortality risk[response]  
  Christenson RH and deFilippi CR, JAMA, 1/1/2011
• Assessment of multiple cardiac biomarkers in non-ST-segment elevation acute coronary syndromes: observations from the MERLIN-TIMI 36 Trial  
  Scirica BM, Sabatine MS, Jarolim P, Murphy SA, Braunwald E, Morrow DA, Eur Heart J, 1/1/2011
• Effect of spironolactone on patients with atrial fibrillation and structural heart disease  
  Williams RS, Dimas V, Reisch J, Hill JA, Naseem RH, Clin Cardiol, 1/1/2011
• Efficacy and safety of more intensive lowering of LDL cholesterol: a meta-analysis of data from 170,000 participants in 26 randomised trials  
  Cholesterol Treatment Trialists’ (CTT) Collaboration, Lancet, 1/1/2010
• Treatment delay in patients undergoing primary percutaneous coronary intervention for ST-elevation myocardial infarction: a key process analysis of patient and program...  
  Parikh SV, Jacobi JA, Chu E, Addo TA, Warner JJ, Delaney KA, McGuire DK, Cigarroa JE, Murphy SA, Keeley EC, Am Heart J, 1/1/2008
• Management of Cocaine-Associated Chest Pain and Myocardial Infarction A Scientific Statement From the American Heart Association Acute Cardiac Care Committee of the Co...  
  McCord J, Jneid H, Hollander JE, Cercek B, Hsue P, Gibler WB, Ohman EM, Drew B, Philippides G, Newby LK, Circulation, 1/1/2008
• Updated Strategies and Therapies for Reducing Ischemic and Vascular Events (STRIVE) unstable angina/non-ST elevation myocardial infarction critical pathway toolkit  
  Aghababian RV, Ballantyne CM, Berger P, Bhatt DL, Blumenthal R, Boden W, Bresler M, Califf RM, Cannon CP, Chesebro J, Cohen JD, Cohen M, Diercks D, Fonarow GC, Bigler ..., Crit Pathw Cardiol, 1/1/2008
• Racial disparity in clinical outcomes following primary percutaneous coronary intervention for ST elevation myocardial infarction: influence of process of care  
  Jacobi JA, Parikh SV, McGuire DK, Murphy SA, Keeley EC, J Interv Cardiol, 1/1/2007
• Low Molecular Weight Heparin Use in Acute Coronary Syndromes and Percutaneous Coronary Interventions: An Update  
  Link JJ, Warner JJ, Curr Cardio Risk Report, 1/1/2007
• Join now to see all

Books/Book Chapters

• Hurst’s the Heart 
  Chapter: Unstable Angina and Non-ST Elevation Myocardial Infarction 
  Page 1328 - 1353O’Rourke RA, Harrington RAEditors: Fuster V, Fuster V, Walsh RA, Harrington R et al.McGraw Hill, IncEdition 13th,2011
• Cardiac Biomarkers in Clinical Practice 
  Chapter: Emerging Biomarkers in Acute Coronary Syndromes 
  Page 199 - 220Gupta N and de Lemos JAJones & Bartlett Publishers2011
• Decision Making in Medicine, An Algorithmic Approach 
  Chapter: Hypertension 
  Page 80 - 81Baber U and de Lemos JAEditors: Green H.L..Mosby, IncEdition 3rd,2010
• Decision Making in Medicine, An Algorithmic Approach 
  Chapter: Syncope 
  Page 74 - 75Nesbitt WH and de Lemos JAEditors: Green H.L..Mosby, IncEdition 3rd,2010
• Decision Making in Medicine, An Algorithmic Approach 
  Chapter: Hypotension 
  Page 76 - 77Patel MJ and de Lemos JAEditors: Green H.L..Mosby, IncEdition 3rd,2010
• Hurst’s The Heart; Manual of Cardiology 
  Chapter: Diagnosis and Management of Patients with Unstable Angina and Non-ST Elevation Myocardial Infarction 
  Page 296 - 314Matulevicius SA, Rohatgi AEditors: O’Rourke RA, Walsh RA, Fuster V.McGraw Hill, IncEdition 12th,2009
• NT-proBNP as a Biomarker in Cardiovascular Diseaeses 
  Chapter: NT-proBNP in General Population-Based Testing 
  Page 23 - 34de Lemos JAEditors: Bayes-Genis A, Januzzi JL.Thomson Reuters2008
• Hurst’s the Heart 
  Chapter: Unstable Angina and Non-ST Elevation Elevation Myocardial Infarction 
  Page 1351 - 1375de Lemos JA, and O’Rourke RAEditors: Fuster V, O’Rourke RA et al.McGraw Hill, IncEdition 12th,2008
• Manual of Intensive Care Medicine 
  Chapter: ST-Segment Elevation Myocardial Infarction 
  Page 195 - 201Wallace TW and de Lemos JAEditors: Irwin R and Rippe J.Lippincott, Williams, & WilkinsEdition 4th,2006
• Cardiac Biomarkers in the Management of Cardiovascular Disease 
  Chapter: Natriuretic Peptides in Acute and Chronic Coronary Artery Disease 
  Page 409 - 426Abdullah SM, de Lemos JAEditors: Morrow DA.The Humana Press2006
• Essential Cardiology 
  Chapter: ST Elevation Myocardial Infarction 
  Deo R, Cannon CPEditors: Rosendorf C.WB SaundersEdition 2nd,2005
• Chronic Coronary Artery Disease in American College of Cardiology Self Assessment Program (ACCSAP) 
  Chapter: Traditional and Novel Risk Factors 
  de Lemos JAEditors: Rutherford JD.American College of CardiologyEdition 6th,2005
• Cardiac Markers 
  Chapter: Management of the Acute Coronary Syndromes 
  Aroney CN, de Lemos JAEditors: Wu A.The Humana Press2004
• Sindromes Coronarios Agudos 
  Chapter: Treatment of Unstable Angina and Non-ST Elevation Myocardial Infarction 
  Page 229 - 255Cogan J, Cannon CPEditors: Llevadot J.Elsevier, Spain2003
• Cardiology Core Curriculum: A Problem-Based Approach 
  Chapter: Acute Coronary Syndromes 
  de Lemos JAEditors: Rutherford JD.BMJ Books2003
• Irwin and Rippe’s Intensive Care Medicine 
  Chapter: ST Elevation Myocardial Infarction 
  Page 400 - 413de Lemos JAEditors: Irwin R and Rippe J.Lippincott, William and WilkinsEdition 5th,2003
• American College of Cardiology Self Assessment Program (ACCSAP) 
  Chapter: Traditional and Novel Risk Factors 
  de Lemos JAEditors: Lewis, RP.American College of CardiologyEdition 5th,2002
• Essential Cardiology 
  Chapter: Acute Myocardial Infarction 
  Page 463 - 501Cannon CP, Stone PHEditors: Rosendorf C.WB Saunders2001
• European Textbook of Clinical Pharmacology 
  Chapter: Angina and Coronary Heart Disease 
  Page 269 - 285de Lemos JA, Cannon CPEditors: Sirtori C.McGraw2000
• Thrombolytic Therapy: New Standards of Care-Part VI 
  Chapter: Reocclusion after AMI: glycoprotein IIa/IIIa receptor inhibitors and percutaneous revascularization as adjuncts to thrombolytic therapy 
  Page 3 - 11de Lemos JA, Cannon CPExcerpta Medica, Inc.1998
• Join now to see all

Lectures

• Year in Review Speaker 
  2019 ACC Scientific Session & Expo, New Orleans - 3/18/2019
• Analyzing the Data: Blockbuster Trials in Acute and Stable Ischemic Heart Disease 
  2019 ACC Scientific Session & Expo, New Orleans - 3/17/2019
• Audience ARS Question 
  2019 ACC Scientific Session & Expo, New Orleans - 3/17/2019
• High Sensitivity TroponinWhy Is it Important to Your Practice? 
  2019 ACC Scientific Session & Expo, New Orleans - 3/16/2019
• Acute Coronary Syndromes 
  Multiple Locations, 2005, 2013, 2014 - 1/1/2015
• Highly sensitive troponin assays: one step back and two steps forward? 
  University of Utah, Salt Lake City, UT - 1/1/2015
• Highly sensitive troponin assays: new opportunities amid existing challenges 
  University of Arizona, Tuczon, AZ - 1/1/2015
• Biomarkers for heart failure prediction: a path forward to prevention? 
  Oslo, Norway - 1/1/2014
• Non ST Elevation Acute Coronary Syndromes 
  Las Vegas, NE, 2007, 2008, 2009; Chicago, IL, 2011, 2012, 2013 - 1/1/2014
• Pharmacology of Antithrombotic Agents 
  Las Vegas, NE, 2007, 2008, 2009; Chicago, IL, 2011, 2012, 2013 - 1/1/2014
• The changing face of the coronary care unit 
  Chicago, IL - 1/1/2014
• Highly sensitive troponin assays 
  Mid America Heart Institute, Kansas City, MO - 1/1/2014
• Innovation in antiplatelet therapy for ACS: can we improve efficacy without causing bleeding? 
  Washington DC - 1/1/2014
• Vascular Risk Factors Over the Course of the Lifeteime 
  Montreal, Canada - 1/1/2013
• Biomarkers of Cardiac Stress and Injury 
  Amstersdam, Netherlands - 1/1/2013
• Rapid Fire Update in ACS 
  Chicago, IL, 2012; San Francisco, CA, 2013 - 1/1/2013
• Screening healthy individuals for heart disease: where are we and where are we going? 
  Tyler, TX, 2012; Williamsburg, VA, 2013 - 1/1/2013
• Highly sensitive assays for cardiac troponins 
  Houston, TX - 1/1/2013
• Advances in Cardiac Biomarker Science: Implications for the Practitioner 
  Boston, MA - 1/1/2013
• High sensitivity troponin assays will drive the cardiologist to drink 
  San Francisco, CA - 1/1/2013
• Antiplatelet agents in ACS 
  Baylor Medical Center, Dallas, TX - 1/1/2013
• Inflammatory mediators of atherosclerosis with relevance to psoriasis 
  Stockholm, Sweeden - 1/1/2012
• Biomarkers in cardiovascular disease: promises, pitfallas, and practical solutions 
  Penn State Medical Center, Hershey, PA - 1/1/2012
• Screening the population for heart disease using highly sensitive troponin assays 
  Carmel, CA - 1/1/2012
• Stable angina; role of medical therapy and revascularizaton 
  Los Angeles, CA - 1/1/2012
• Join now to see all

Other

• Secondary prevention after acute coronary syndromes 
  Thompson PD, Lavie C, Kiernan F, Med Roundtable Cardiovasc Ed
  1/1/2014
• Elevated cardiac troponin identifies a malignant phenotype of left ventricular hypertrophy 
  Neeland IJ, de Lemos JA, ACCEL Interview
  1/1/2013
• Implications of highly sensitive troponin assays 
  de Lemos JA, Cardiosource Web Site, American College of Cardiology Foundation
  1/1/2011
• Which is more important: plaque quantity or plaque rupture? 
  Roberts WC, Libby P, Med Roundtable Cardiovasc Ed
  1/1/2011
• Role of the Cardiologist in the Management of the Morbidly Obese Patient [transcript] 
  de Lemos JA, Cardiosource Web Site, American College of Cardiology Foundation
  http://www.cardiosource.com/expertopinions/programHlts/interviewDetail.asp?interviewID=347.
  1/10/2008
• Multiple Biomarker Strategies in Coronary Artery Disease [transcript] 
  de Lemos JA, Cardiosource Web Site, American College of Cardiology Foundation
  http://www.cardiosource.com/expertopinions/programHlts/interviewDetail.asp?interviewID=325.
  1/5/2007
• Novel Cardiac Biomarkers in ACS 
  de Lemos JA, Fuster V, ACCEL Interview
  1/1/2005
• Biomarkers 
  Peacock F, Ohman M, and Hutter D, ACC Convervations with Experts
  1/1/2005
• BNP and other cardiac markers in ACS 
  de Lemos JA, Fye B, ACCEL Interview
  1/1/2004
• Beyond TIMI 3 Flow: from arterial to myocardial perfusion 
  de Lemos JA, Gersh B, ACCEL Interview
  1/1/2002
• Improving Reperfusion in Acute Myocardial Infarction: Glycoprotein IIb/IIIa Receptor Inhibitors and Percutaneous Revascularization as Adjuncts to Thrombolytic Therapy 
  de Lemos JA, Cannon, CP, Chest Pain Online
  www.chestpainonline.org
  1/1/2000
• Emerging Role of Chlamydia Pneumonia in Inflammation and Coronary Artery Disease 
  de Lemos JA, Chest Pain Online
  www.chestpainonline.org
  1/1/2000
• The ACS Continuum: Current and Emerging Management Strategies 
  de Lemos JA, Kuvin JT, American Heart Association Webcast
• Managing Lipids in High Risk Patient Populations 
  Giugliano RP, Blazing MA, Braun LT, A Cardiosource Virtual Learning Ininiative
  www.cardiosource.com/lipids
• Join now to see all